17085-Myelofibrosis-NA-517

Myelofibrosis

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Address

3700 W State Route 89A
Sedona, AZ 86336
P: (928) 204-4163

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.